| Christopher Alfonso Manipula, MD | |
|
12220 Iron Bridge Rd, Suite A, Chester, VA 23831-1543 | |
| (804) 706-5827 | |
| (804) 706-5819 |
| Full Name | Christopher Alfonso Manipula |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 12220 Iron Bridge Rd, Chester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871884528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101258474 (Virginia) | Primary |
| Entity Name | Dominion Women's Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932289592 PECOS PAC ID: 1456327824 Enrollment ID: O20040907001241 |
News Archive
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
› Verified 8 days ago
| Entity Name | West End Obstetrics & Gynecology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194751867 PECOS PAC ID: 2163433970 Enrollment ID: O20060508000965 |
News Archive
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
› Verified 8 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Alfonso Manipula, MD 12220 Iron Bridge Rd, Suite A, Chester, VA 23831-1543 Ph: (804) 706-5827 | Christopher Alfonso Manipula, MD 12220 Iron Bridge Rd, Suite A, Chester, VA 23831-1543 Ph: (804) 706-5827 |
News Archive
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Colorectal cancer remains the second leading cause of cancer death for men and women combined in the U.S. The goal of screening is to reduce the number of people who die from this common cancer. According to Mayo Clinic cancer experts there are gaps in current screening approaches in terms of detection accuracy, patient willingness to use them, and accessibility.
› Verified 8 days ago
Mrs. Linda K Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12801 Iron Bridge Rd, Suite 100, Chester, VA 23831 Phone: 804-706-5827 Fax: 804-706-5819 |